Statins in diseases of the peripheral arteries: are the clinical recommendations being followed?
- Authors: Paranina E.V.1, Krivoshchekov E.P.1, Paranin P.O.1
-
Affiliations:
- Samara State Medical University, Ministry of Health of Russia
- Issue: Vol 35, No 9 (2024)
- Pages: 69-71
- Section: From Practice
- URL: https://journals.rcsi.science/0236-3054/article/view/266794
- DOI: https://doi.org/10.29296/25877305-2024-09-14
- ID: 266794
Cite item
Open Access
Access granted
Subscription Access
Abstract
Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis and is associated with high mortality due to cardiovascular events. Since lipid-lowering therapy has proven effective in the treatment of patients with PAD, current clinical guidelines regulate statin treatment for all patients with PAD. However, in real clinical practice, the administration of statins in this category of patients is clearly insufficient.
The purpose of this study was to study compliance with current clinical recommendations on the frequency of statin prescribing in various regimens among patients with PAD who sought medical help in a specialized hospital.
It has been shown that in real clinical practice, the administration of statins does not comply with current clinical recommendations, and the desired low-density lipoproteins targets are not achieved in a significant number of patients. It is necessary to raise awareness among doctors of various specialties about the need for early diagnosis and treatment of PAD in accordance with clinical recommendations, especially in the absence of coronary heart disease and other atherosclerosis-associated diseases. When diagnosed with PAD, the patient should start taking statins in the most tolerable doses with the most effective drugs.
Full Text
##article.viewOnOriginalSite##About the authors
E. V. Paranina
Samara State Medical University, Ministry of Health of Russia
Author for correspondence.
Email: eles77@list.ru
Candidate of Medical Sciences
Russian Federation, SamaraE. P. Krivoshchekov
Samara State Medical University, Ministry of Health of Russia
Email: eles77@list.ru
Doctor of Medical Sciences, Professor
Russian Federation, SamaraP. O. Paranin
Samara State Medical University, Ministry of Health of Russia
Email: eles77@list.ru
Russian Federation, Samara
References
- Nosova E.V., Conte M.S., Grenon S.M. Advancing beyond the “heart-healthy diet” for peripheral arterial disease. J Vasc Surg. 2015; 61 (1): 265–74. doi: 10.1016/j.jvs.2014.10.022
- Song P., Rudan D., Zhu Y. et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019; 7 (8): e1020–e30. doi: 10.1016/S2214-109X(19)30255-4
- Fawkes F.G., Rudan D., Rudan I. et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013; 382 (9901): 1329–40. doi: 10.1016/S0140-6736(13)61249-0
- Joosten M.M., Pai J.K., Bertoia M.L. et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA. 2012; 308 (16): 1660–7. doi: 10.1001/jama.2012.13415
- Sagris M., Kokkinidis D.G., Lempesis I.G. et al. Nutrition, dietary habits, and weight management to prevent and treat patients with peripheral artery disease. Rev Cardiovasc Med. 2020; 21 (4): 565–75. doi: 10.31083/j.rcm.2020.04.202
- Theofilis P., Sagris M., Antonopoulos A.S. et al. Inflammatory mediators of platelet activation: focus on atherosclerosis and COVID-19. Int J Mol Sci. 2021; 22 (20): 11170. doi: 10.3390/ijms222011170
- Deem S., Allenberg J.R., Pittrow D. et al. Mortality and vascular morbidity in people with asymptomatic or symptomatic peripheral arterial disease. Circulation. 2009; 120 (21): 2053–61. doi: 10.1161/CIRCULATIONAHA.109.865600
- Aung P.P., Maxwell H., Jepson R.G. et al. Lipid-lowering drugs for diseases of the peripheral arteries of the lower extremities. Cochrane Database Syst. 2007; 2007 (4): CD000123. doi: 10.1002/14651858.CD000123.pub2
- Harris S.K., Roos M.G., Landry G. Statin use in patients with peripheral arterial disease. J Vasc Surg. 2016; 64 (6): 1881–8. doi: 10.1016/j.jvs.2016.08.094
- Кухарчук В.В., Ежов М.В., Сергиенко И.В. и др. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации, VII пересмотр. Атеросклероз и дислипидемии. 2020; 1 (38): 7–42 [Kukharchuk V.V., Ezhov M.V., Sergienko I.V. et al. Diagnostics and correction of lipid metabolism disorders to prevent and treat atherosclerosis. Russian Recommendations, VII revision. Atherosclerosis and dyslipidemia. 2020; 1 (38): 7–42 (in Russ.)]. doi: 10.34687/2219-8202.JAD.2020.01.0002
- Рекомендации ЕSC/EAS по лечению дислипидемий: модификация липидов для снижения сердечно-сосудистого риска. Российский кардиологический журнал. 2020; 25 (5): 3826 [The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Russian Journal of Cardiology. 2020; 25 (5): 3826 (in Russ.)]. doi: 10.15829/1560-4071-2020-382
Supplementary files
